Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?

BACKGROUND: Exploring the cancer risks of rheumatoid arthritis (RA) patients with disease-modifying anti-rheumatic drugs (DMARDs) can help detect, evaluate, and treat malignancies at an early stage for these patients. Thus, a comprehensive analysis was conducted to determine the cancer risk of RA pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuzhuo, Lin, Jiangpeng, You, Zhixuan, Tu, Hengjia, He, Peng, Li, Jiarong, Gao, Rui, Liu, Ziyu, Xi, Zhiyuan, Li, Zekun, Lu, Yi, Hu, Qiyuan, Li, Chenhui, Ge, Fan, Huo, Zhenyu, Qiao, Guibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807750/
https://www.ncbi.nlm.nih.gov/pubmed/36605209
http://dx.doi.org/10.3389/fimmu.2022.1050876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807750/
https://www.ncbi.nlm.nih.gov/pubmed/36605209
http://dx.doi.org/10.3389/fimmu.2022.1050876

Ejemplares similares